中德临床肿瘤学杂志（英文版）2011，Vol.10Issue(9)：551-553,3.DOI:10.1007/s10330-011-0856-x
重组人血管内皮抑素联合GC方案治疗晚期非小细胞肺癌1例报道
Endostar combined GC in the treatment of advanced non-small cell lung cancer: a case report
Changlin Zhao 1Junbo Yuan 1Ganlu Zhang 1Fangjuan Hu 1Xi Yu 1Mingzhi Ren 1Wenjun Zhang1
作者信息
摘要
Abstract
Abstract A 43-year-old female with a 3-month history of paroxysmal irritating cough presented progressive chest tightness and shortness of breath. Laboratory data showed elevated carcino-embryonic antigen (CEA). Further imaging studies revealed a soft tissue mass shadow was in right middle lobe lung with mediastinal and sub-carinal lymph nodes enlarged.Biopsy diagnosis: moderately and poorly differentiated adenocarcinoma of the lung. Clinical diagnosis: central non-small cell lung cancer (NSCLC) of right middle lobe (CIVT4N2M1), lung adenocarcinoma G2–3, malignant pleural effusion, pericardial effusion, hilar and mediastina lymph node metastases. After 4 cycles of endostar plus GC therapy, imaging studies revealed showed soft tissue mass in right middle lobe disappeared, and evaluation of short-term result was complete remission (CR).PFS has been seven months till now. Therefore, this report provided strong evidence that endostatin combined GC treatment for advanced NSCLC is safe and effective, which can prolong survival and improve quality of life.关键词
lung tumor/non-small cell lung cancer (NSCLC)/advanced/endostar/chemotherapyKey words
lung tumor/non-small cell lung cancer (NSCLC)/advanced/endostar/chemotherapy引用本文复制引用
Changlin Zhao,Junbo Yuan,Ganlu Zhang,Fangjuan Hu,Xi Yu,Mingzhi Ren,Wenjun Zhang..重组人血管内皮抑素联合GC方案治疗晚期非小细胞肺癌1例报道[J].中德临床肿瘤学杂志（英文版）,2011,10(9):551-553,3.
